Overview

Update
Acquisitions
1 Acquisition
Total Equity Funding
$34.8M in 1 Round from 3 Investors
Headquarters:
Atlanta, GA
Description:
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
Founders:
Categories:
Pharmaceutical, Biotechnology, Life Science
Website:
http://www.arborpharma.com
Social:

Company Details

Update

Arbor Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, Inc. was founded in 2006 and is based in Raleigh, North Carolina.

Funding Rounds (1) - $34.8M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2010$34.8M / Series B3

Acquisitions (1)

Update
DateAcquiredAmount
May 20, 2016$467M in Cash

Current Team (12)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • HQ

    980 Hammond Drive

    Building Two, Suite 1250

    Atlanta, GA 30328

    USA

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos